eHTA Session 1 post-event survey – NMIN – Nanomedicines Innovation Network

1. Which of the following statements is true about the technology readiness level (TRL) framework? Select ONE answer.

The technology readiness level (TRL) framework was originally developed by pharmaceutical companies to assess their R&D pipeline.
The technology readiness level (TRL) framework is based on a scale from 1 to 15 with 15 being the most mature technology.
The technology readiness level (TRL) framework is based on a scale from 1 to 9 with 9 being the most mature technology.
The technology readiness level (TRL) framework was originally developed by the FDA to assess a health technology readiness for regulatory approval.

2. In what ways is the health technology market different than most markets? Select ALL that apply.

The consumers are often not the payers
Consumers need third-party authorization to access many medical products
Efficacy usually needs to be demonstrated in addition to safety to meet regulatory requirements
Consumers and payers are looking for the same information when deciding about the product

3. Why was Exubera pulled off the market? Select ALL that apply.

4. How likely are you to recommend this webinar to a friend or colleague?

Selected Value: 0

0 = Not at all likely, 10 = Extremely likely

5. How likely are you to incorporate the lessons from this webinar in your future work?

Selected Value: 0

0 = Not at all likely, 10 = Extremely likely

6. Please describe at least one new concept you learned from this webinar.

7. Please describe at least one concept in this webinar that you didn’t understand.